How GLSA’s Clinical Research Technology Solutions Enhance Preclinical and Clinical Research In the dynamic world of life sciences, the journey from discovery to market approval is filled with challenges. Organizations face numerous scientific, regulatory, and logistical hurdles while striving to bring innovative therapies to patients. Global Life Sciences Alliance (GLSA) addresses these challenges through their… Read more »
Category: GLSA Solutions
GLSA’s Patient-Centric Approach to Clinical Trials
Elevating Research Through Patient-Centric Strategies: The GLSA Approach to Recruitment, Engagement, and Retention The path from discovery to delivery is complex in both preclinical and clinical research. Challenges related to patient recruitment, engagement, and retention often determine whether a study succeeds or stalls. A patient-centric approach helps address these issues by placing the participant experience… Read more »
Practical Pointers for Product Development and Medical Affairs
MedSurgPI proudly shares the April 2025 Practical Pointers, which focus on key strategies in clinical development and medical affairs to improve the success of complex clinical trials and product launches. This paper outlines practical approaches, including leveraging AI, fostering patient engagement, and aligning early with commercial and regulatory goals. For more on MedSurgPI, visit: www.medsurgpi.com.
Optimizing Clinical Trial Budgets and Protocols with GLSA’s Solutions Team
How GLSA’s Clinical Research Solutions Team Optimizes Preclinical and Clinical Research In the dynamic landscape of life sciences, optimizing clinical trial budgets and protocols is essential for bringing new treatments to market. The journey from discovery to approval involves navigating complex scientific challenges, regulatory requirements, and patient engagement strategies. Moreover, this journey is often long… Read more »
GLSA Global Advisory Network Accelerates Clinical Research
How GLSA’s Global Advisory Network Accelerates Pre-Clinical and Clinical Research In the fast-paced world of life sciences, GLSA’s Global Advisory Network plays a critical role in accelerating pre-clinical and clinical research by helping organizations overcome scientific challenges, regulatory hurdles, and patient recruitment needs. This expertise allows life sciences companies to bring new therapies to market… Read more »
GLSA Network Driving Innovation in Life Sciences Research
Unlocking Innovation in Life Sciences with Global Life Sciences Alliance (GLSA) In the ever-evolving landscape of life sciences, the journey from concept to cure is fraught with challenges. Researchers and organizations constantly seek ways to accelerate studies while maintaining rigor and compliance. Enter the Global Life Sciences Alliance and its extensive, global network— GLSA driving… Read more »
Fast-Tracking Breakthroughs: How GLSA Fuels Clinical Success
How GLSA’s Global Advisory Network Accelerates Pre-Clinical and Clinical Research Global advisory support for clinical research is essential in today’s fast-moving life sciences environment. Developing new therapies requires navigating scientific complexity, regulatory requirements, and patient recruitment challenges. The journey from discovery to market approval is long. Each phase introduces new risks and decisions. This is… Read more »
Dispelling the Myth: Plug-and-Play Solutions in Clinical Trials
Plug-and-Play Clinical Trial Outsourcing: A Smarter CRO Model Plug-and-play clinical trial outsourcing is often described as unrealistic in complex CRO–sponsor relationships. However, at the 11th Annual Outsourcing in Clinical Trials Nordics meeting in Copenhagen, that assumption was directly challenged. Instead, we believe plug-and-play solutions do exist, and Global Life Sciences Alliance (GLSA) proves that every… Read more »
Clinical Trials in the Philippines: A Strategic Advantage for Global Studies
Global Reach for Clinical Trials: Why the Philippines Is a Strategic Advantage GLSA offers global reach for clinical trials through our trusted network of Clinical Research Organizations (CROs). In particular, this article highlights the advantages of conducting clinical trials in the Philippines—a region that continues to emerge as a strategic hub for XUS studies. Through… Read more »
Decentralized Clinical Trials
Decentralized Clinical Trials: How COVID Accelerated Remote Research So much has changed as a result of the COVID-19 pandemic. Activities we once took for granted became difficult—or impossible—as the world adjusted to contain the virus. One of the most significant disruptions occurred in the way new medicines are developed. Clinical trials remain essential to advancing… Read more »